Ptc Therapeutics, Inc. · NASDAQ:PTCT
Janus Henderson Group PLC reported a 6.00% stake in Ptc Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Janus Henderson Group PLC reported a 6.00% stake in Ptc Therapeutics, Inc., 4,851,332 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 4,851,332
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 6.00% | 4,851,332 |
Source
Related
- Ptc Therapeutics, Inc.
- Janus Henderson Group PLC
- Ptc Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Form 4 · Schmertzler Michael · Oct 16, 2026
- Form 4 · Boulding Mark Elliott · Oct 13, 2026
- Form 4 · Schmertzler Michael · Oct 9, 2026
- Form 4 · Boulding Mark Elliott · Oct 7, 2026
- Form 4 · Steele Glenn Jr Md Phd · Oct 2, 2026